IMMUNOGENICITY OF DNA VACCINE CONSTRUCTS ENCODING INFLUENZA VIRUS ARTIFICIAL ANTIGENS

封面

如何引用文章

全文:

详细

Development of a universal influenza vaccine is an important task. One of approaches for develop a universal influenza vaccine is design of artificial immunogens, which consist of fragments from proteins of diff erent subtypes of influenza virus. Candidate universal DNA-vaccine were design in the FBSI SRC VB «Vector» earlier. The vaccine encode artificial antigens designed on the basis of conservative fragments of the hemagglutinin stem from influenza A virus of two subtypes H1N1 and H3N2, and on the basis of conservative protein M2. The article presents results of a study of the T-cell immune response in mice that were immunized with DNA-vaccine constructs encoding the designed influenza virus antigens.

作者简介

E. Starostina

State Research Center of Virology and Biotechnology «Vector» Rospotrebnadzor

编辑信件的主要联系方式.
Email: starostina_ev@vector.nsc.ru

researcher of Bioengineering Department,

Koltsovo, Novosibirsk region

俄罗斯联邦

O. Kaplina

State Research Center of Virology and Biotechnology «Vector» Rospotrebnadzor

Email: fake@neicon.ru

researcher of Bioengineering Department,

Koltsovo, Novosibirsk region

俄罗斯联邦

L. Karpenko

State Research Center of Virology and Biotechnology «Vector» Rospotrebnadzor

Email: fake@neicon.ru

PhD, Dr. Sci., head of Recombinant vaccines Laboratory of Bioengineering Department,

Koltsovo, Novosibirsk region

俄罗斯联邦

S. Dudko

State Research Center of Virology and Biotechnology «Vector» Rospotrebnadzor

Email: fake@neicon.ru

researcher of Bioengineering Department, 

Koltsovo, Novosibirsk region

俄罗斯联邦

S. Bazhan

State Research Center of Virology and Biotechnology «Vector» Rospotrebnadzor

Email: fake@neicon.ru

PhD, Dr. Sci., head of Theoretical Department,

Koltsovo, Novosibirsk region

俄罗斯联邦

参考

  1. Wacheck V., Egorov A., Groiss F., Pfeiff er A., Fuereder T., Hoefl mayer D., Kundi M., Popow-Kraupp T., Redlberger-Fritz M., Mueller C.A., Cinatl J., Michaelis M., Geiler J., Bergmann M., Romanova J., Roethl E., Morokutti A., Wolschek M., Ferko B., Seipelt J., DickGudenus R., Muster T. A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1. J Infect Dis. 2010, 1; 201(3), 354–62.
  2. López-Macías C. Virus-like particle (VLP)-based vaccines for pandemic infl uenza: performance of a VLP vaccine during the 2009 influenza pandemic. Hum Vaccin Immunother. 2012, 8(3), 411–4.
  3. Draper S. J., Cottingham M. G., Gilbert S. C. Utilizing poxviral vectored vaccines for antibody inductionprogress and prospects. Vaccine 2013, 31, 4223–30. 4. Vemula S. V., Ahi Y. S., Swaim A. M., Katz J. M., Donis R., Sambhara S., Mittal S. K. Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness. PLoS One 2013, 8, 624–96.

版权所有 © Starostina E.V., Kaplina O.N., Karpenko L.I., Dudko S.G., Bazhan S.I., 2019

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可
##common.cookie##